CP-IVX001
14 Sep 2023
Trial Summary
This is a Phase 1 open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in people with micro satellite-stable (MSS) colorectal or gastroesophageal cancer metastatic to liver, or advanced ovarian cancer.
Acronym:
CP-IVX001
ACTRN/NCT /ethics:
NCT05427487
Scientific title:
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours
Sponsor / Cooperative group:
ImmVirx Pty Ltd
Trial & Patient Characteristics
| Cancer Type | All |
|---|---|
| Trial Type | Treatment |
| Phase | Phase I |
| Age Range | 18 to 85 years |
| Sex | - |
| Tumour Stream | - |
| Cancer Stage | - |
| Anticipated Start Date | 2023-02-17 |
| Anticipated End Date | 2024-09-01 |
Participating Hospitals
| Hospital | The Queen Elizabeth Hospital |
|---|---|
| Clinical Trial Coordinator | Pamela Cooper |
| Pamela.cooper@sa.gov.au | |
| Phone | 08 8222 6140 |
| Principal Investigator | Tim Price |
| Recruitment Status | Recruiting |